Renaissance Technologies’s Cantel Medical Corporation CMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-128,225
| Closed | -$10.2M | – | 3921 |
|
|
2021
Q1 | $10.2M | Buy |
128,225
+122,500
| +2,140% | +$9.57M | 0.01% | 1182 |
|
|
2020
Q4 | $451K | Buy |
+5,725
| New | +$336K | ﹤0.01% | 2865 |
|
|
2019
Q1 | – | Sell |
-75,025
| Closed | -$5.59M | – | 3795 |
|
|
2018
Q4 | $5.59M | Sell |
75,025
-11,100
| -13% | -$916K | 0.01% | 1649 |
|
|
2018
Q3 | $7.93M | Buy |
+86,125
| New | +$8.2M | 0.01% | 1502 |
|
|
2017
Q1 | – | Sell |
-4,900
| Closed | -$386K | – | 3490 |
|
|
2016
Q4 | $386K | Sell |
4,900
-21,425
| -81% | -$1.66M | ﹤0.01% | 2843 |
|
|
2016
Q3 | $2.05M | Buy |
+26,325
| New | +$1.91M | ﹤0.01% | 2177 |
|
|
2016
Q2 | – | Sell |
-25,825
| Closed | -$1.84M | – | 3581 |
|
|
2016
Q1 | $1.84M | Sell |
25,825
-5,644
| -18% | -$354K | ﹤0.01% | 2269 |
|
|
2015
Q4 | $1.96M | Buy |
+31,469
| New | +$1.92M | ﹤0.01% | 2126 |
|
|
2015
Q2 | – | Sell |
-9,300
| Closed | -$442K | – | 3450 |
|
|
2015
Q1 | $442K | Sell |
9,300
-5,800
| -38% | -$257K | ﹤0.01% | 2646 |
|
|
2014
Q4 | $653K | Sell |
15,100
-18,550
| -55% | -$758K | ﹤0.01% | 2332 |
|
|
2014
Q3 | $1.16M | Sell |
33,650
-11,800
| -26% | -$417K | ﹤0.01% | 1957 |
|
|
2014
Q2 | $1.66M | Sell |
45,450
-22,100
| -33% | -$750K | ﹤0.01% | 1820 |
|
|
2014
Q1 | $2.28M | Buy |
67,550
+24,200
| +56% | +$798K | 0.01% | 1700 |
|
|
2013
Q4 | $1.47M | Buy |
43,350
+32,400
| +296% | +$1.12M | ﹤0.01% | 1898 |
|
|
2013
Q3 | $349K | Sell |
10,950
-7,200
| -40% | -$191K | ﹤0.01% | 2420 |
|
|
2013
Q2 | $410K | Buy |
+18,150
| New | +$393K | ﹤0.01% | 2306 |
|
Renaissance Technologies's CMD Position: Q2 2021 in Review
Renaissance Technologies sold out of Cantel Medical Corporation (CMD) in Q2 2021, closing a stake of 128,225 shares — an estimated $10.2M sold.
Renaissance Technologies first reported a position in CMD in Q2 2013 and held it in 16 quarters. The position peaked at $10.2M in Q1 2021. 0 funds tracked by Wall St. Rank hold CMD as of Q2 2021.
- Renaissance Technologies reported no remaining Cantel Medical Corporation position as of Q2 2021 after selling out during the quarter.
- Renaissance Technologies sold 128,225 Cantel Medical Corporation shares in Q2 2021, an estimated $10.2M.
- Renaissance Technologies first reported a position in Cantel Medical Corporation in Q2 2013 and held it in 16 quarters.
- Renaissance Technologies's Cantel Medical Corporation position peaked at $10.2M in Q1 2021.
- 0 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2021.
Based on Renaissance Technologies's 13F filing for Q2 2021, filed 13 Aug 2021.